Laura A. Marlow - Concepedia

Author

Laura A. Marlow

Mayo Clinic in Florida ORCID

Also Known As

L A Marlow, L. A. Marlow, L. Marlow, Laura A Marlow, Laura A. Marlow, Laura Marlow

149

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Florida Jacksonville College Mayo Clinic WinnMed Mayo Clinic in Arizona

About

Laura A. Marlow is an author at Mayo Clinic in Florida specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.1K
2	Cell Biology	11	11	795
3	Natural Sciences	4	4	226
4	Biochemistry	4	4	250
5	Health Sciences	2	2	49

Laura A. Marlow

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification Rebecca E. Schweppe, Joshua Klopper, Christopher Korch, The Journal of Clinical Endocrinology & Metabolism	2008	563
Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma Christina A. Von Roemeling, Laura A. Marlow, Johnny J. Wei, Clinical Cancer Research	2013	273
Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme Elizabeth A. Eckman, Mona Watson, Laura A. Marlow, Journal of Biological Chemistry	2003	258
Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4 Christina A. Von Roemeling, Derek C. Radisky, Laura A. Marlow, Cancer Research Renal InflammationPathologyAmpa-selective Glutamate Receptor-4Cancer BiologyTumor Biology	2014	221
Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma Han W. Tun, Laura A. Marlow, Christina A. Von Roemeling, PLoS ONE	2010	182
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies Iñigo Landa, Nikita Pozdeyev, Christopher Korch, Clinical Cancer Research	2019	182
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target Christina A. Von Roemeling, Laura A. Marlow, Anthony B. Pinkerton, The Journal of Clinical Endocrinology & Metabolism	2015	177
Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1 John A. Copland, Laura A. Marlow, Shinichi Kurakata, Oncogene OncologyMedicineCancer Cell BiologyAnti-cancer AgentCancer Treatment	2005	132
Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial Robert C. Smallridge, John A. Copland, Marcia S. Brose, The Journal of Clinical Endocrinology & Metabolism	2013	112
p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression Edwin Soto, Masahiro Yanagisawa, Laura A. Marlow, The Journal of Cell Biology Tumor BiologyTumor Cell GrowthSignaling PathwayP120 Catenin InducesMedicine	2008	91

Page 1